Vifor Pharma to acquire Sanifit, a clinical-stage cardio-renal biopharmaceutical company focused on treatments for progressive vascular calcification disorders, complementing and strengthening the Group’s growing nephrology portfolio. Sanifit, based in Palma (Spain) has had the backing of international and Spanish funds, among which are the CataloniaBio  & HealthTech members Alta Life Sciences, Ysios Capital and Healthequity, as well as Caixa Capital Risc, Columbus Venture Partners, and Innvierte from CDTI.

Under the terms of the acquisition agreement, Vifor Pharma will acquire 100% of the outstanding shares in Sanifit Therapeutics, receiving full global rights for SNF472, further enhancing the company’s portfolio of ...

MJN-neuro has opened crowdequity round of one million euros on the Capital  Cell platform to fund the business plan of the new device MJN-Seras, the first portable device that is able to predict the likelihood of suffering an epileptic seizure. The company, a CataloniaBio & HealthTech  member, has already exceeded one million euros in less than 5 months and expects to reach 120%. In addition, the round has been extended to allow the entry of a major Danish Family Office.

During this period, the value of the company has tripled, and, after the participation of American and Spanish investors, it ...

The investment company specializing in biotechnology and health, and a member of CataloniaBio & HealthTech, Capital  Cell, has raised 14 million euros. They are higher figures than the 13.5 million it raised throughout the 2020 financial year.

The director of the company, Daniel Oliver, sets the goal of reaching 16 million by the end of the current year. With this growth, Capital Cell could once again be the leader in crowdfunding in Spain in 2021.

Capital Cell was founded in 2015 as the first online investment platform in Europe specializing in biotechnology and health. Among the successes of the ...

The European Investment Bank (EIB) will provide Anaconda  Biomed, the medical device start-up and CataloniaBio & HelathTech  member, with venture debt funding of up to €10 million to support the  development of its second generation of catheter for the treatment of acute  ischemic stroke (AIS). This is the second venture debt operation in Spain backed by European Guarantee Fund (EGF) — part of the €540 billion EU response to the economic impact of COVID-19.

The EIB will provide long-term funding at favourable rates with flexible repayment. This will enable Anaconda Biomed to test the next generation of catheters to improve ...

BHV Partners, the venture builder specializing in the health sector and a member  of CataloniaBio & HealthTech, opens a new round of investment aimed at private investors in the health and financial sectors, to consolidate their growth. With this round of investment, it wants to raise 500,000 euros to  strengthen the professional team and develop its range of health projects.

Founded two years ago, BHV Partners has projects in its portfolio that are already advancing towards the market to offer solutions to unmet medical needs. These include Adan Medical, members of CataloniaBio &  HealthTech, who develop devices for anaphylaxis ...